When considering return of agony or withdrawal because of adverse events as loss of response (LTR), procedure with LYRICA resulted in a longer the perfect time to loss of therapeutic reaction than therapy with placebo. Fifty-a few percent with the pregabalin-treated subjects when compared to 33% of placebo individuals remained on study drug and pre